BACKGROUND: This study tested the hypothesis that use of semantic organizational strategy in approaching the Mattis Dementia Rating Scale (MDRS) complex verbal initiation/perseveration (CV I/P) task, a test of semantic fluency, is the function specifically associated with remission of late-life depression. METHOD: Seventy elders with major depression participated in a 12-week escitalopram treatment trial. Neuropsychologic performance was assessed at baseline after a 2-week drug washout period. Patients with a Hamilton Depression Rating Scale Score ≤7 for 2 consecutive weeks and who no longer met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria were considered to be remitted. Cox's proportional hazards survival analysis was used to examine the relationship between subtests of the I/P, other neuropsychologic domains, and remission rate. Participants' performance on the CV I/P subscale was coded for perseverations, and use of semantic strategy. RESULTS: The relationship between the performance on the CV I/P subscale and remission rate was significant. No other subtest of the MDRS I/P evidenced this association. There was no significant relationship between speed, confrontation naming, verbal memory, or perseveration with remission rate. Remitters' use of verbal strategy was significantly greater than nonremitters. CONCLUSIONS: Geriatric depressed patients who showed decrements in performance on a semantic fluency task showed poorer remission rates than those who showed adequate performance on this measure. Executive impairment in verbal strategy explained performance. This finding supports the concept that executive functioning exerts a "top down" effect on other basic cognitive processes, perhaps as a result of frontostriatal network dysfunction implicated in geriatric depression.
BACKGROUND: This study tested the hypothesis that use of semantic organizational strategy in approaching the Mattis Dementia Rating Scale (MDRS) complex verbal initiation/perseveration (CV I/P) task, a test of semantic fluency, is the function specifically associated with remission of late-life depression. METHOD: Seventy elders with major depression participated in a 12-week escitalopram treatment trial. Neuropsychologic performance was assessed at baseline after a 2-week drug washout period. Patients with a Hamilton Depression Rating Scale Score ≤7 for 2 consecutive weeks and who no longer met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria were considered to be remitted. Cox's proportional hazards survival analysis was used to examine the relationship between subtests of the I/P, other neuropsychologic domains, and remission rate. Participants' performance on the CV I/P subscale was coded for perseverations, and use of semantic strategy. RESULTS: The relationship between the performance on the CV I/P subscale and remission rate was significant. No other subtest of the MDRS I/P evidenced this association. There was no significant relationship between speed, confrontation naming, verbal memory, or perseveration with remission rate. Remitters' use of verbal strategy was significantly greater than nonremitters. CONCLUSIONS: Geriatric depressedpatients who showed decrements in performance on a semantic fluency task showed poorer remission rates than those who showed adequate performance on this measure. Executive impairment in verbal strategy explained performance. This finding supports the concept that executive functioning exerts a "top down" effect on other basic cognitive processes, perhaps as a result of frontostriatal network dysfunction implicated in geriatric depression.
Authors: Brian T Gold; David A Balota; Sara J Jones; David K Powell; Charles D Smith; Anders H Andersen Journal: J Neurosci Date: 2006-06-14 Impact factor: 6.167
Authors: Tyler J Story; Guy G Potter; Deborah K Attix; Kathleen A Welsh-Bohmer; David C Steffens Journal: Am J Geriatr Psychiatry Date: 2008-08-12 Impact factor: 4.105
Authors: George S Alexopoulos; Dimitris N Kiosses; Moonseong Heo; Christopher F Murphy; Bindu Shanmugham; Faith Gunning-Dixon Journal: Biol Psychiatry Date: 2005-08-01 Impact factor: 13.382
Authors: Christopher F Murphy; Faith M Gunning-Dixon; Matthew J Hoptman; Kelvin O Lim; Babak Ardekani; Jessica K Shields; Jan Hrabe; Dora Kanellopoulos; Bindu R Shanmugham; George S Alexopoulos Journal: Biol Psychiatry Date: 2006-11-21 Impact factor: 13.382
Authors: George S Alexopoulos; Dimitris N Kiosses; Christopher Murphy; Moonseong Heo Journal: Neuropsychopharmacology Date: 2004-12 Impact factor: 7.853
Authors: George S Alexopoulos; Christopher F Murphy; Faith M Gunning-Dixon; Vassilios Latoussakis; Dora Kanellopoulos; Sibel Klimstra; Kelvin O Lim; Matthew J Hoptman Journal: Am J Psychiatry Date: 2008-01-02 Impact factor: 18.112
Authors: Joel R Sneed; Steven P Roose; John G Keilp; K Ranga Rama Krishnan; George S Alexopoulos; Harold A Sackeim Journal: Am J Geriatr Psychiatry Date: 2007-07 Impact factor: 4.105
Authors: Guy G Potter; Andrew D Blackwell; Douglas R McQuoid; Martha E Payne; David C Steffens; Barbara J Sahakian; Kathleen A Welsh-Bohmer; K R Ranga Krishnan Journal: Neuropsychopharmacology Date: 2007-02-14 Impact factor: 7.853
Authors: Monique A Pimontel; David Rindskopf; Bret R Rutherford; Patrick J Brown; Steven P Roose; Joel R Sneed Journal: Am J Geriatr Psychiatry Date: 2015-05-21 Impact factor: 4.105
Authors: Sarah Shizuko Morimoto; Dora Kanellopoulos; Kevin J Manning; George S Alexopoulos Journal: Ann N Y Acad Sci Date: 2015-02-05 Impact factor: 5.691
Authors: Sarah Shizuko Morimoto; Faith M Gunning; Dora Kanellopoulos; Christopher F Murphy; Sibel A Klimstra; Robert E Kelly; George S Alexopoulos Journal: Int J Geriatr Psychiatry Date: 2011-05-25 Impact factor: 3.485
Authors: Katie L Bessette; Aimee J Karstens; Natania A Crane; Amy T Peters; Jonathan P Stange; Kathleen H Elverman; Sarah Shizuko Morimoto; Sara L Weisenbach; Scott A Langenecker Journal: Neuropsychol Rev Date: 2020-01-15 Impact factor: 7.444
Authors: Dolores Gallagher Thompson; Shelli R Kesler; Keith Sudheimer; Kala Mehendra Mehta; Larry W Thompson; Renee M Marquett; Jason M Holland; Robert Reiser; Natalie Rasgon; Alan Schatzberg; Ruth M O'Hara Journal: Am J Geriatr Psychiatry Date: 2014-02-18 Impact factor: 4.105